Results 181 to 190 of about 24,520 (233)

Podophyllotoxin sensitizes triple-negative breast cancer cells to CD47-targeted immunotherapy. [PDF]

Cell Insight
Dang J, Song N, Zhou J, Raoof M, Feng M.
europepmc   +1 more source

SIRPα ablated iPSC-derived macrophages resist hypophagia and enhance mAb-dependent and CAR-mediated cytotoxicity of solid tumors. [PDF]

Mol Ther Oncol
Smith PR, Kabir ME, Zhang J, Maufort JP, Forsberg MH, Sedzro DM, Berres M, Thomson JA, Capitini CM, Slukvin II.   +9 more
europepmc   +1 more source

Recent advances in preclinical studies combining hyperthermia therapy with novel immune checkpoint targeting agents. [PDF]

Front Immunol
Li N, Yu J, Wang R, Gong G.
europepmc   +1 more source

Spatial immune atlas of breast cancer brain metastasis reveals CD163⁺ macrophage reprogramming associated with immune escape. [PDF]

J Immunother Cancer
Zhu J, Ye J, Ma Y, Lin Z, Wen Y, Sheng J, Yang M.   +6 more
europepmc   +1 more source

Engineering macrophages for effective and safe targeting of CD47 cancer cells in the tumor microenvironment. [PDF]

J Immunother Cancer
Andón FT, Rosales Sánchez A, Pensado-López A, García-Campelo R, Takimoto CH.   +4 more
europepmc   +1 more source

Low-dose DOX-polygodial nanosystem modulates the CD47/CALR axis for safer triple negative breast cancer treatment. [PDF]

Nanoscale Adv
Emara HM, Youness RA, Manie TM, Abdelnaser A, Allam NK.   +4 more
europepmc   +1 more source

MYC promotes the progression of prostate cancer by regulating CD47 to induce an immunosuppressive microenvironment. [PDF]

Cell Mol Life Sci
Xin S, Su J, Zhao L, Li R, Li G, Qin W, Zhang Z, Wang C, Zhu Y, Feng L, Sun X, Jin L, Zhai T, Mei W, Gao Z.   +14 more
europepmc   +1 more source

IgG4 anti-CD47: Erythrophagocytosis and potential transfusion complications. [PDF]

Transfusion
Boligan KF, Loriamini M, Holton MB, Sandhu G, Binnington B, Velliquette R, Westhoff CM, Branch DR.   +7 more
europepmc   +1 more source

CD47 blockade (ALX301) enhances immunoradiotherapy response in HPV negative head and neck squamous cell carcinoma. [PDF]

PLoS One
Monther A, Al-Msari R, Saddawi-Konefka R, Fassardi S, Tang C, Philips C, Sen P, Mohammadzadeh P, Decker K, Miyauchi S, Roy S, Jones R, Wu X, Gutkind S, Sharabi A, Califano J.   +15 more
europepmc   +1 more source

Selective Targeting of Immune Checkpoints HLA-G and CD47 Using Novel Dual Signaling Protein DSP216 Promotes Innate Anticancer Immunity. [PDF]

Adv Sci (Weinh)
Jacob LJ, Tamir L, Abdeen M, Tamir A, Aronin A, Bloch I, Kahn R, Pecker I, Tykocinski M, Huls G, Pereg Y, Chajut A, Bremer E.   +12 more
europepmc   +1 more source